The European Commission has launched a formal procedure against the French government over its regulation of the pharmacy sector, which Brussels says is out of step with European Union market rules.
The Commission has written a warning letter to the authorities in Paris as a first step in the process, giving the government two months to respond. The objection is to the constraints on pharmacy ownership imposed on the country's 23,000 pharmacies. The owner of a pharmacy under French law is not allowed to own more than one pharmacy and has to be a qualified pharmacist rather than a businessman or entrepreneur.
These rules are strongly defended in France by the pharmacy organizations but generally prevent the formation of pharmacy chains. However, the current position in the tussle between Paris and Brussels is that France has succeeded, so far, in convincing the European Commission that the rules do enable pharmacies to be established all over the country, including the heavily rural areas, rather than be concentrated in areas of higher population density.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze